Avertix Medical, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-23.
Avertix Medical, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 23, 2025. The filing reports $1.01M sold. Its industry group is Other Health Care. It names Tom Mendell (Director), Christopher Pucillo (Director), Timothy Moran (Executive Officer, Director) (SEC Form D, September 23, 2025).
Is this your company?
Sell to companies like Avertix Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Avertix Medical, Inc.
Free to see. No signup.
Get an email when Avertix Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Avertix Medical, Inc. raises, hires or launches. No email unless you switch it on.
Watch Avertix Medical, Inc. →Get the full cited report on Avertix Medical, Inc.
What the filing shows about Avertix Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Avertix Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Avertix Medical, Inc.'s address as 40 Christopher Way, Suite 201, Eatontown, NJ 07724.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Avertix Medical, Inc. is a registered filer with the SEC (CIK 1564031) and has filed since 2023-03-01. 7 filings are on record, the latest on 2025-09-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Avertix Medical, Inc.'s Form D of 2025-09-23 names Tom Mendell, Christopher Pucillo, Timothy Moran and 5 more as its officers, directors or promoters.
Its new offerings report $55.90M sold across 5 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 871 filings in Other Health Care, totalled by week.
Tom Mendell is named as Director on the Form D that Avertix Medical, Inc. filed with the SEC on 23 September 2025, one of 8 people that filing names.
Christopher Pucillo is named as Director on the Form D that Avertix Medical, Inc. filed with the SEC on 23 September 2025, one of 8 people that filing names.
Timothy Moran is named as Executive Officer and Director on the Form D that Avertix Medical, Inc. filed with the SEC on 23 September 2025, one of 8 people that filing names.
Joseph Berardo is named as Director on the Form D that Avertix Medical, Inc. filed with the SEC on 23 September 2025, one of 8 people that filing names.
Phillip Tom is named as Executive Officer on the Form D that Avertix Medical, Inc. filed with the SEC on 23 September 2025, one of 8 people that filing names.
David Keenan is named as Executive Officer on the Form D that Avertix Medical, Inc. filed with the SEC on 23 September 2025, one of 8 people that filing names.
Richard Schatz is named as Director on the Form D that Avertix Medical, Inc. filed with the SEC on 23 September 2025, one of 8 people that filing names.
Sean Cullinan is named as Director on the Form D that Avertix Medical, Inc. filed with the SEC on 23 September 2025, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2025-09-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Avertix Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Avertix Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Avertix Medical, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Avertix Medical, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Avertix Medical, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Avertix Medical, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/avertix-medical-inc-form-d-25000001